ArticleDiscover oncology2026

Oxaliplatin upregulates Cyr61 expression by inhibiting the Hippo-YAP pathway which contributes to drug resistance of colorectal cancer cells.

Pingxia Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.